The invention relates to 4-methyl-2,3,5,9,9b-pentaaza-cyclopenta[a]naphthalene derivatives of general formula (I) which are inhibitors of phosphodiesterase 2 and/or 10, useful in treating central nervous system diseases and other diseases. In addition, the invention relates to processes for preparing pharmaceutical compositions as well as processes for manufacture the compounds according to the invention.
The invention relates inter alia to compounds of the general formula (I)
in which the A
1
-A
4
, T, n, W, Q, R
1
and B
1
-B
4
radicals are each as defined in the description. Also described are processes for preparing the compounds of the formula (I). The inventive compounds are especially suitable for controlling insects, arachnids and nematodes in agriculture, and ectoparasites in veterinary medicine.
The invention relates to antiparasitic combinations comprising inter alia to compounds of the general formula (I) in which the A1-A4, T, n, W, Q, R1 and B1 -B4 radicals are each as defined in the description. Also described are processes for preparing the compounds of the formula (I). The combinations further comprise ectoparasiciticides, anthelmintics or anti-protozoal agents. The combinations are especially suitable for controlling ectoparasites, helminths and/or protozoa on or in animals.
The invention relates inter alia to compounds of the general formula (I)
in which the A1-A4, T, n, W, Q, R1 and B1-B4 radicals are each as defined in the description. Also described are processes for preparing the compounds of the formula (I). The inventive compounds are especially suitable for controlling insects, arachnids and nematodes in agriculture, and ectoparasites in veterinary medicine.